Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 12-21

  Zangrilli, J ^a,b   Robertson, N ^b   Shetty, A ^a   Wu, J ^a   Hastie, A ^a   Fish, J E ^a   Litwack, G ^b   Peters, S P ^a  

^a Division of Pulmonary and Critical Care   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bcl 2; Caspase; Eosinophil; Fas; IL 5

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 5; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LYSATE; CELL SURVIVAL; CELL VIABILITY; DRUG EFFECT; ENZYME ACTIVATION; EOSINOPHIL; GENE TARGETING; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0034107113     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01173.x     Document Type: Article

References (38)

1. Zangrilli JG, Robertson NM, Alnemri E et al. Expression of ICE/CED- 3 related cysteine proteases and Bcl-2 in human eosinophils. Am J Respir Crit Care Med 1996; 153:A56(Abstr.).
2. Druilhe A, Arock M, Le Goff L, Pretolani M. Human eosinophils express Bcl-2 family proteins: modulation of Mcl-1 expression by IFN- gamma. Am J Respir Cell Mol Biol 1998; 18:315-22.
3. Ochiai K, Kagami M, Matsumura R, Tomioka H. IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up- regulation of bcl-2 expression. Clin Exp Immunol 1997; 107:198-204.
4. L in delayed eosinophil-apoptosis mediated by granulocyte-macrophage colony- stimulating factor and interleukin-5. Blood 1999; 92:778-83.
5. Dewson G, Walsh GM, Wardlaw AJ. Expression of Bcl-2 and its homologues in human eosinophils. Am J Respir Cell Mol Biol 1999; 20:720-8.
6. Egan RW, Umland SP, Cuss FM, Chapman RW. Biology of interleukin-5 and its relevance to allergic disease. Allergy 1996; 51:71-81.
7. Ohnishi T, Kita H, Weiler D et al. IL-5 is the predominant eosinophil- active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147:901-7.
8. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245:308-10.
9. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78:2542-7
10. Her E, Frazer J, Austen KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J Clin Invest 1991; 88:1982-7.
11. Yousefi S, Blaser K, Simon H-U. Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int Arch Allergy Immunol 1998; 112:9-12.
12. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates cell death. Cell 1993; 74:609-19.
13. L and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80:285-91.
14. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-6.
15. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597-608.
16. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig R. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993; 90:3516-20.
17. Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 1997; 64:33-42.
18. Tewari M. Quan LT, O'Rourke K et al. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate Poly (ADP-ribose) polymerase. Cell 1995; 81:801-9.
19. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89:175-84.
20. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD- homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 1996; 85:817-27.
21. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vivo. Blood 1995; 86:1437-43.
22. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APo-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-Iike cysteine proteases. Proc Natl Acad Sci USA 1996; 93:14486-91.
23. Fernandes-Alnemri T, Litwack G, Alnemri E. CPP32, a novel human apoptotic protein with homology to Caenorhabdiris elegant cell death protein CED-3 and mammalian interleukin-1-beta-converting enzyme. J Biol Chem 1994; 269:30761-4.
24. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J et al. The Ced-3/IL- lβ converting enzyme-like homologue Mch6 and the lamin cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J Biol Chem 1996; 271:27099-106.
25. Hansel TT, De Vries TJ, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145:105-10.
26. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-56.
27. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas x can mediate apoptosis. Cell 1991; 66:233-43.
28. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, Lazebnik YA. Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci USA 1998; 95:13664-9.
29. Scaffidi C, Medema JP, Krammer PH, Peter ME. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 1997; 272:26953-8.
30. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson KB, Korsemyer SJ. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995; 92:7834-8.
31. Antonsson B, Conti F, Ciavatta AM et al. Inhibition of Bax channel forming activity by Bcl-2. Science 1997; 277:370-2.
32. Sattler M, Liang H, Nettesheim D et al. Structure of Bcl-x sub L-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275:983-6.
33. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278:1966-8.
34. Clem RJ, Cheng EH, Karp CL et al. Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 1998; 95:554-9.
35. Kang JJ, Schaber MD, Srinivasula SM, Alnemri ES, Litwack G, Hall DJ, Bjornsti M-A. Cascades of mammalian caspase activation in the yeast Sacchammyces cerevisiae. J Biol Chem 1999; 274:3189-98.
36. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-89.
37. Hamann KJ, Dorscheid DR, Ko FD, Conforti AE, Sperling AI, Rabe KF, White SR. Expression of fas (CD95) and fast (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol 1998; 19:537-42.
38. Druile A, Wallaert B, Tsicopoulos A, Lapa e Silva J-R, Tillie-Leblond I, Tonnel A-B, Pretolani M. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1999; 19:747-57.